EUVIMEDEUVIMED entdecken
Crossref

HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study

Zhiyuan Li, Qing Shao, Hongqun Qiao iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Zhiyuan Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Sodium-Glucose Transporter 2 Inhibitors, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A sensitive and robust HPLC‐MS/MS method was developed and validated for the simultaneous determination of YWS22026 and its major metabolite M3 in rat plasma using protein precipitation. Chromatographic separation was achieved on a Shim‐pack Scepter C18 column (4.6 × 50 mm, 3 μm) with a gradient elution program (mobile phase A: 0.2% formic acid in water; mobile phase B: methanol) at a flow rate of 0.9 mL/min. Detection was performed via positive electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode. The method demonstrated excellent specificity, accuracy (relative error, %RE < 9.1%), precision (relative standard deviation, %RSD < 9.9%), and linearity (5–2000 ng/mL for both analytes). The lower limit of quantification (LLOQ) was 5 ng/mL. Stability studies confirmed that plasma samples remained stable under various storage conditions (at room temperature for 10 h, −20°C for 22 days, three freeze–thaw cycles, and 4°C autosampler storage for 73 h). This validated method was successfully applied to a 26‐week concomitant toxicokinetic study in Sprague–Dawley rats, which revealed significant sex‐related differences in exposure for both YWS22026 and M3. These findings provide valuable insights for informing the safety assessment of YWS22026 in subsequent clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySodium-Glucose Transporter 2 InhibitorsLiquid Chromatography-Mass SpectrometryAnimalsChromatography, High Pressure LiquidRatsReproducibility of ResultsRats, Sprague-DawleyMaleLinear ModelsLimit of DetectionToxicokineticsDrug Stability

Stichwörter der Autor:innen

HPLC‐MS/MSYWS22026metabolitetoxicokinetics

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
  • Jiangsu Center for Safety Evaluation of Drugs, Jiangsu Provincial Institute of Materia Medica, Nanjing, China.

ORCID-Profile: Hongqun Qiao

Zitieren

APA

Li, Z., Shao, Q., & Qiao, H. (2026). HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70366

Vancouver

Li Z, Shao Q, Qiao H. HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study. Biomedical Chromatography. 2026. doi:10.1002/bmc.70366

BibTeX
@article{Li2026,
  author = {Li, Zhiyuan and Shao, Qing and Qiao, Hongqun},
  title = {HPLC‐MS/MS Method for the Simultaneous Quantification of SGLT2 Inhibitor YWS22026 and Its M3 Metabolite in Rat Plasma, With Application to Toxicokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70366}
}
Kostenlos starten →